These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31415584)

  • 1. Development of a high-throughput assay to measure measles neutralizing antibodies.
    Alvarado-Facundo E; Audet S; Moss WJ; Beeler JA
    PLoS One; 2019; 14(8):e0220780. PubMed ID: 31415584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases.
    Sowers SB; Rota JS; Hickman CJ; Mercader S; Redd S; McNall RJ; Williams N; McGrew M; Walls ML; Rota PA; Bellini WJ
    Clin Vaccine Immunol; 2016 Aug; 23(8):707-16. PubMed ID: 27335386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.
    Haralambieva IH; Ovsyannikova IG; Vierkant RA; Poland GA
    Clin Vaccine Immunol; 2008 Jul; 15(7):1054-9. PubMed ID: 18463223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles Foci Reduction Neutralization Test (FRNT).
    Santibanez S; Mankertz A
    Methods Mol Biol; 2024; 2808():209-224. PubMed ID: 38743373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of complement and difference of cell-based assay and ELISA in determination of neutralization capacity against mumps and measles virus.
    Brgles M; Kurtović T; Lang Balija M; Hećimović A; Mušlin T; Halassy B
    J Immunol Methods; 2021 Mar; 490():112957. PubMed ID: 33412172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.
    Nates SV; Rey GY; Giordano MO; Depetris AR; Boshell J
    Viral Immunol; 1995; 8(1):47-52. PubMed ID: 8546804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of measles virus-specific neutralizing antibodies: evaluation of the syncytium inhibition assay in comparison with the plaque reduction neutralization test.
    Ward BJ; Aouchiche S; Martel N; Bertley FM; Bautista-Lopez N; Serhir B; Ratnam S
    Diagn Microbiol Infect Dis; 1999 Mar; 33(3):147-52. PubMed ID: 10092962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine.
    Haralambieva IH; Ovsyannikova IG; O'Byrne M; Pankratz VS; Jacobson RM; Poland GA
    Vaccine; 2011 Jun; 29(27):4485-91. PubMed ID: 21539880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cells.
    Wang X; Peden K; Murata H
    Vaccine; 2015 Dec; 33(51):7254-7261. PubMed ID: 26552003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an enzyme-linked immunosorbent assay for immunoglobulin M antibodies against measles virus.
    Roodbari F; Roustai MH; Mostafaie A; Soleimanjdahi H; Foroshani RS; Sabahi F
    Clin Diagn Lab Immunol; 2003 May; 10(3):439-42. PubMed ID: 12738645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.
    Bouche F; Ammerlaan W; Berthet F; Houard S; Schneider F; Muller CP
    J Clin Microbiol; 1998 Mar; 36(3):721-6. PubMed ID: 9508302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody.
    Klingele M; Hartter HK; Adu F; Ammerlaan W; Ikusika W; Muller CP
    J Med Virol; 2000 Sep; 62(1):91-8. PubMed ID: 10935994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient, reproducible and accurate RT-qPCR based method to determine mumps specific neutralizing antibody.
    Sikazwe CT; Levy A; Speers D; Smith DW
    J Virol Methods; 2020 Mar; 277():113817. PubMed ID: 31911119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody.
    Lee MS; Cohen B; Hand J; Nokes DJ
    J Virol Methods; 1999 Mar; 78(1-2):209-17. PubMed ID: 10204711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new neutralization test for measles virus.
    Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
    J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative reverse-transcription PCR.
    Teferedegne B; Lewis AM; Peden K; Murata H
    PLoS One; 2013; 8(2):e56023. PubMed ID: 23437084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment.
    Varada JC; Teferedegne B; Crim RL; Mdluli T; Audet S; Peden K; Beeler J; Murata H
    Virol J; 2013 Jun; 10():195. PubMed ID: 23767960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.
    Weigle KA; Murphy MD; Brunell PA
    J Clin Microbiol; 1984 Mar; 19(3):376-9. PubMed ID: 6371044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay.
    Cohen BJ; Parry RP; Doblas D; Samuel D; Warrener L; Andrews N; Brown D
    J Virol Methods; 2006 Feb; 131(2):209-12. PubMed ID: 16188328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.